Oridonin derivative ameliorates experimental colitis by inhibiting activated T‐cells and translocation of nuclear factor‐kappa B

Publisher： John Wiley & Sons Inc

E-ISSN： 1751-2980|17|2|104-112

ISSN： 1751-2972

Source： Journal of Digestive Diseases, Vol.17, Iss.2, 2016-02, pp. : 104-112

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Nuclear factor-kappa B inhibitors; a patent review (2006 – 2010)

By Kwak Jae-Hwan Jung Jae-Kyung Lee Heesoon

Expert Opinion on Therapeutic Patents, Vol. 21, Iss. 12, 2011-12 ,pp. : 1897-1910

Informa Healthcare

Access to resources Recommend Favorite

Direct Covalent Modification as a Strategy to Inhibit Nuclear Factor-Kappa B

Current Medicinal Chemistry, Vol. 16, Iss. 32, 2009-11 ,pp. : 4261-4273

Bentham Science Publishers

Access to resources Recommend Favorite

Lipopolysaccharide activates Akt in vascular smooth muscle cells resulting in induction of inducible nitric oxide synthase through nuclear factor-kappa B activation

By Hattori Y. Hattori S. Kasai K.

European Journal of Pharmacology, Vol. 481, Iss. 2, 2003-11 ,pp. : 153-158

Elsevier

Access to resources Recommend Favorite

Oxymatrine inhibits lipopolysaccharide-induced inflammation by down-regulating Toll-like receptor 4/nuclear factor-kappa B in macrophages

By Zhang Yu Yan Ruhong Hu Yae

Canadian Journal of Physiology and Pharmacology, Vol. 93, Iss. 4, 2015-01 ,pp. : 253-260

NRC Research Press

Access to resources Recommend Favorite

Nuclear factor kappa B and hepatitis viruses

By Guan Yong-Song He Qing Wang Ming-Quan Li Ping

Expert Opinion on Therapeutic Targets, Vol. 12, Iss. 3, 2008-03 ,pp. : 265-280

Informa Healthcare

Access to resources Recommend Favorite